• Art Jahnke

    Senior Contributing Editor

    Art Janke

    Art Jahnke began his career at the Real Paper, a Boston area alternative weekly. He has worked as a writer and editor at Boston Magazine, web editorial director at CXO Media, and executive editor in Marketing & Communications at Boston University, where his work was honored with many awards. Profile

Comments & Discussion

Boston University moderates comments to facilitate an informed, substantive, civil conversation. Abusive, profane, self-promotional, misleading, incoherent or off-topic comments will be rejected. Moderators are staffed during regular business hours (EST) and can only accept comments written in English. Statistics or facts must include a citation or a link to the citation.

There is 1 comment on What the Supreme Court’s Gene Decision Means to Research

  1. The article states that the “cost” of Myriad’s test was $3,000 but that is the PRICE set by the monopoly patent holder – the COST would be a small fraction of that.

    I wonder — if Myriad had been less greedy and a bit more willing to share this technology (which was NOT developed by Myriad, by the way….but by an academic who was one of the plaintiffs) whether the outcome would have been different. We’ll never know but I’m thrilled with this finding. First time I knowingly agree with an opinion by Clarence Thomas!

Post a comment.

Your email address will not be published. Required fields are marked *